Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05322382
Other study ID # 008_SPO_CV_OS_USF
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date June 2, 2021
Est. completion date June 3, 2021

Study information

Verified date April 2022
Source CardiacSense Ltd.
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This project aims to test the accuracy of pulse oximeters during mild, moderate, and severe hypoxia, i.e., a range of arterial HbO2 saturation from 100 down to 70%. A typical study will include at least ten subjects (at least 200 necessary data points to meet the ISO 80601-2-61:2017).


Description:

After local anesthetic injection, a 22-gauge catheter is inserted in one radial artery. Pulse oximeters are attached to fingers, ears, or flat body surfaces. Subjects are in a comfortable semi-recumbent position. Subjects then breathe air mixtures containing reduced amounts of oxygen to produce the desired level of hypoxemia. Stable, safe, and controlled hypoxia is breath-by-breath by breath respiratory gas analysis and a computer program that permits the inspired gas mixture to be adjusted to achieve a level of lung alveolar gas that will achieve the desired degree of saturation.


Recruitment information / eligibility

Status Completed
Enrollment 12
Est. completion date June 3, 2021
Est. primary completion date June 3, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 50 Years
Eligibility Inclusion Criteria: 1. The subject is male or female, aged =18 and <50. 2. The subject is in good general health with no evidence of any medical problems. 3. The subject is fluent in both written and spoken English. 4. The subject has provided informed consent and is willing to comply with the study procedures. Exclusion Criteria: 1. The subject is obese (BMI>30). 2. The subject has a known history of heart disease, lung disease, kidney or liver disease. 3. Diagnosis of asthma, sleep apnea, or use of CPAP. 4. Subject has diabetes. 5. Subject has a clotting disorder.

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
A-line
Subjects breathe air mixtures containing reduced amounts of oxygen to produce the desired level of hypoxemia.

Locations

Country Name City State
United States University of California at San Francisco San Francisco California

Sponsors (1)

Lead Sponsor Collaborator
CardiacSense Ltd.

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Accuracy of pulse oximeter with profound hypoxia Perform accurate measurement of a range of arterial HbO2 saturation from 100 to down to 70% during mild, moderate, and severe hypoxia. 2 days
See also
  Status Clinical Trial Phase
Withdrawn NCT00730119 - Evaluation Of The GE Monitor Product Line N/A
Completed NCT01605955 - Fingertip Pulse Oximeter Clinical Test N/A
Completed NCT05896267 - SpO2 Data Collection in Pediatric Patients Using INVSENSOR00061 N/A
Recruiting NCT06204822 - Non-contact Blood Pressure and SpO2 Measurement Based on Image Sensor
Not yet recruiting NCT06398262 - Alar SpO2 Sensor Study
Enrolling by invitation NCT05681637 - SpO2 Difference Between Fingers of the Hand During Sequential Desaturation and Step Resaturation N/A
Completed NCT05876650 - Pilates Exercises v/s Yoga on Rounded Shoulders N/A
Not yet recruiting NCT06372106 - Project Mountain - Comparing SpO2 and SaO2 for Accuracy